Global Cell Signaling Market - Segmented by Signaling Type, Product, Technology, Pathway, Application and Geography - Growth, Trends and Forecast (2022 - 2030)

The global cell signaling market is projected to grow at a CAGR of approximately 6.5% during the forecast period (2018-2023). Cell signaling is part of the complex system of communication that is involved in cellular physiology and functional regulation. Consequently cell signaling finds application in metabolism analysis, secretion mechanism elucidation, enzyme synthesis and up-regulation of the immune system.

Increased Funding for Cell-Based Research

According to the data available on the portal for National Institutes of Health (NIH), an estimated 1748 million USD was granted for stem cell research in fiscal year 2018. In contrast the actual fund grants for stem cell research in fiscal year 2017 amounted to 1646 million USD. Similar increments in funding grants were observed for research in the areas of embryonic stem cell and induced pluripotent stem cell. Similar positive trends in fund grants increment have been observed in European Union for cell-based research. Consequently, the increasing participation of government for the development of cell-based research in the form of incremental funding is expected to drive the growth of the global cell signaling market. Other factors contributing to the growth of the global cell signaling market include the increasing incidence of chronic diseases and technological advancements in cell-based research instruments.

Ethical Issues Related to Embryonic Stem Cell Signaling Research

Human stem cell research is subject to ethical and political controversies. The derivation of pluripotent stem cell lines from oocytes and embryos is highly disputed because it is related with alteration of human personhood and human reproduction. Adult stem cells or cord blood stem cells are not associated with ethical concerns and are widely exploited in research and clinical care. However, these cells cannot be expanded in-vitro and in most cases lack pluripotency. Embryonic stem cells on the other hand are more pliable for expansion due to their high propensity for pluripotency. However, human embryonic stem cell (hESC) research is ethically and politically controversial because it involves the destruction of human embryos. In US, the destruction of embryos for deriving pluripotent cell lines is considered similar to abortion and raises the ethical dilemma of controlling life. Such ethical controversies act as a bad press for the entire community of researchers engaged in exploring pluripotent stem cell lines from embryos. Consequently, ethical issues related to embryonic stem cell signaling research is acting as a restraint in the growth of the global cell signaling market. Other factor which is causing hindrance in market growth include high cost of cell signaling system.

Akt Pathway to Lead the Cell Signaling Market in Pathway Segment

Misregulation of AKt pathway is associated with malignancy and apoptosis. Consequently Akt pathway holds special importance in oncology studies. Additionally, aberrant activation of Akt pathway is associated with anomalies in angiogenesis which is defined as the formation of new blood vessels. Cell signaling research in the field of Akt pathway is consequently of utmost priority among the academic researchers. A large fraction of existing portfolio of commercially available cell-based therapies are based on regulation of Akt pathway and there are many more in pipelines stages. Consequently, Akt pathway leads the global cell signaling market in the pathway category and is expected to continue with similar trend over the forecast period.

Key Developments in Cell Signaling Market

• Apr 2018: Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, announced the opening of a new office in Shanghai, China in order to support the rapidly expanding China life science market and the growth of the CST business in the country.

Major Players: BECKMAN COULTER INC., BECTON DICKINSON AND COMPANY, BIO-RAD LABORATORIES INC., BIO-TECHNE CORPORATION, CELL SIGNALING TECHNOLOGY INC., MERCK KGAA, PERKINELMER INC., PROMEGA CORPORATION, QIAGEN N.V., and THERMO FISHER SCIENTIFIC INC. among others.

Reasons to Purchase Cell Signaling Market Report

• Current and future global cell signaling market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players
• 3-month analyst support along with the Market Estimate sheet (in Excel)

Customization of Cell Signaling Market Report

• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports